Results 291 to 300 of about 2,148,890 (355)

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

Infectious, Allergic, and Immune-Mediated Disease Data Resources: a Landscape Overview and Subset Assessment. [PDF]

open access: yesJ Med Syst
Pokutnaya D   +6 more
europepmc   +1 more source

Investigating the role of cytochrome <i>bd</i> oxidases in the antibacterial activity of madecassic acid and derivatives thereof. [PDF]

open access: yesRSC Med Chem
Henry SA   +10 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Biological Assays

2017
The biological ...
Rowhani A   +4 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy